Top Companies in Healthcare Analytical Testing Services

The global healthcare analytical testing services market is projected to reach USD 12.48 billion by 2030 from USD 7.48 billion in 2025, at a CAGR of 10.8%. The growth in this market is driven by increasing investments, supportive funds & grants for research on pharmaceuticals, the growing significance of biomolecular analysis, and the rising demand for chromatography solutions in applied industries.

The healthcare analytical testing services market is moderately competitive, with established companies and emerging players vying for market shares. Leading players have implemented key strategies in the past four years, including launches, forming agreements, and pursuing expansions. As of 2024, the key companies operating in the global healthcare analytical testing services market include Eurofins Scientific SE (Luxembourg), WuXi AppTec (China), Intertek Group Plc (UK), ICON Plc (Ireland), and IQVIA (US).

To know about the assumptions considered for the study download the pdf brochure

Eurofins Scientific SE (Luxembourg) has established itself as a leading provider capable of delivering exceptional results globally, effectively serving clients across the entire value chain. Through its expansive network, the company outpaces competitors and achieves significant economies of scale, benefiting both itself and its clients and thereby enhancing shareholder value. With the completion of its laboratory network in Europe and North America, Eurofins now stands as a market leader, equipped with scale and scientific expertise to offer improved, quicker, and more cost-efficient services to its clientele. While continuing its growth in North America and Europe, the company expands and refines its contract laboratory network in the Asia Pacific region. Eurofins' Biopharmaceutical Product Testing (BPT) entities also operate the largest network of independent harmonized bio/pharmaceutical GMP product testing laboratories, serving leading pharmaceutical, biopharmaceutical, and medical device companies worldwide. These labs offer comprehensive services, from starting materials to finished product and package testing, with a range of methodologies under GMP authorization, ISO 17025 accreditation, and ISO 9000 certification.

WuXi AppTec (China) held a major position in the healthcare analytical testing services market in 2024. The company primarily offers laboratory and manufacturing outsourcing solutions to pharmaceutical, biopharmaceutical, and medical device firms, boasting a diverse portfolio of discovery and development services. It maintains a robust customer base, particularly in China, the US, Germany, Iceland, Israel, and Korea. To sustain its leadership and expand its market share, the company prioritizes meeting and exceeding customer expectations by ensuring service quality and adapting swiftly to changing conditions. Strategically, WuXi focuses on global expansion to enhance its capabilities and capacity, alongside employing growth tactics like mergers, collaborations, agreements, and service launches. For instance, WuXi STA acquired the Bristol-Myers Squibb manufacturing facility in Couvet, Switzerland, while WuXi ATU established a new facility in Philadelphia, tripling its testing capacity to better serve its global clientele. These initiatives reinforce the company's commitment to delivering distinctive, high-quality services.

Market Ranking

The healthcare analytical testing services market is competitive, with five major players accounting for 60–65% of the overall market share. These include Eurofins Scientific SE (Luxembourg), WuXi AppTec (China), Intertek Group Plc (UK), ICON Plc (Ireland), and IQVIA (US).

Eurofins Scientific SE leads in healthcare analytical testing services with a global lab network and comprehensive testing across pharmaceutical, genomic, food, and environmental segments. The company enhances its position through strategic acquisitions and digitalization, supporting regulatory compliance and product quality assurance. WuXi AppTec offers integrated R&D and analytical testing services for the entire drug development pipeline. It emphasizes innovation and regulatory alignment to help biopharma clients accelerate timelines and ensure quality standards. Investments in advanced instrumentation and global expansion boost its service scalability. Intertek Group Plc supports healthcare and pharmaceutical companies with expertise in quality assurance and regulatory testing, offering tailored solutions for safety and performance evaluation. Its commitment to reliability and transparency fosters strong client partnerships. ICON Plc combines analytical testing with clinical development, utilizing scientific expertise and real-world data to optimize decision-making and reduce time-to-market. Collaborations in biomarker development enhance its service differentiation. IQVIA blends healthcare analytics with testing services to support drug development, delivering integrated solutions for biomarker analysis and clinical trial support. Its focus on data-driven strategies reinforces its position in precision medicine.

Market competition is fueled by advancements in analytical instrumentation, the rising demand for comprehensive testing, evolving regulations, outsourcing trends, and laboratory automation technologies.

Related Reports:

Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com